NCT05580809View on ClinicalTrials.gov

CT Perfusion Parameters for Advanced HCC Treated by Systemic Immunotherapy

CompletedOBSERVATIONAL
Enrollment

9

Participants

Timeline

Start Date

August 1, 2021

Primary Completion Date

June 30, 2022

Study Completion Date

August 30, 2022

Conditions
Advanced HCC Treated by Systemic Immunotherapy
Trial Locations (1)

54000

CHRU Nancy, Nancy

All Listed Sponsors
lead

Valérie LAURENT

OTHER

NCT05580809 - CT Perfusion Parameters for Advanced HCC Treated by Systemic Immunotherapy | Biotech Hunter | Biotech Hunter